Daxor says HFSA study shows blood volume analysis improves diuresis in mechanical pump heart failure patients
Bitget2026/10/14 12:03- Daxor reported new clinical study results already presented at HFSA 2026, alongside signs of rising clinician interest in its BVA diagnostic system.
- Data in high-acuity heart failure patients suggested direct blood-volume measurement can reveal missed fluid and anemia issues, supporting more targeted treatment decisions.
- A separate advanced heart failure analysis indicated BVA can identify a previously hard-to-detect volume condition, positioning the tool as a differentiator in care pathways.
- The update strengthens Daxor’s commercial pitch that improved diagnostic precision could reduce misdiagnosis risk, supporting adoption discussions with hospital clinicians.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Anthropic spends $3.4 billion to purchase gas-fired power equipment to supply electricity for data centers
In September, Anthropic directly acquired Caterpillar equipment orders worth 3.4 billion USD, securing 1.7 GW of gas generator units, marking the largest single purchase of power generation equipment in AI history. This move bypassed utility middlemen, capturing scarce capacity at prices set years ago with near-term delivery. It is part of Anthropic's plan to invest over 895 billion USD in computing infrastructure by 2045.
Why Nintendo Stock Is One to Watch Ahead of the Holiday Season
A wallet address sold 1.44 million TRX via SunSwap in exchange for 460,000 USDT.
Data: Whales have cumulatively withdrawn approximately 13.4 million USDT from a certain exchange.
Crypto prices
More
